As respiratory viruses are expected to surge in the coming months, evolving vaccine guidelines are causing confusion regarding the administration of COVID-19 shots this...
Moderna is poised to seek regulatory approval for its mRNA flu vaccine following a successful Phase III trial. The vaccine, known as mRNA-1010, demonstrated...